These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17223774)
21. [Effects of the RALE study. Hyperkalemia following spironolactone treatment]. Erdmann E Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149 [No Abstract] [Full Text] [Related]
22. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study. Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751 [TBL] [Abstract][Full Text] [Related]
23. ACE inhibitor therapy: benefits and underuse. Smith SC Am Fam Physician; 1999 Jan; 59(1):35-6, 38. PubMed ID: 9917572 [No Abstract] [Full Text] [Related]
24. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics. Chin MH; Wang JC; Zhang JX; Lang RM J Gen Intern Med; 1997 Sep; 12(9):563-6. PubMed ID: 9294790 [TBL] [Abstract][Full Text] [Related]
25. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro]. de Teresa E Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901 [No Abstract] [Full Text] [Related]
26. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra]. RodrÃguez Lambert JL; Moris C Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900 [No Abstract] [Full Text] [Related]
29. The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction. Swedberg K; Sharpe N Eur Heart J; 1996 Sep; 17(9):1306-11. PubMed ID: 8880014 [No Abstract] [Full Text] [Related]
30. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
31. Modern management of hypertension and heart failure: evidence and practice. Hobbs FD Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i35-8; discussion i50. PubMed ID: 10956320 [No Abstract] [Full Text] [Related]
32. ACE inhibitors after myocardial infarction. Poole-Wilson PA Lancet; 1994 Jan; 343(8892):289-90. PubMed ID: 7905109 [No Abstract] [Full Text] [Related]
33. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735 [TBL] [Abstract][Full Text] [Related]
34. Heart failure after myocardial infarction: A good heart is hard to find. Velazquez EJ; O'Connor CM Am Heart J; 1999 Dec; 138(6 Pt 1):1009-11. PubMed ID: 10577426 [No Abstract] [Full Text] [Related]
35. Heart failure and angiotensin-converting enzyme inhibitors: towards evidence-based health care. Cowie MR; Hardman SM Br J Hosp Med; 1995 Mar 1-14; 53(5):186-8. PubMed ID: 7749547 [No Abstract] [Full Text] [Related]
38. ACE inhibitors after myocardial infarction. Jackson G Br J Clin Pract; 1995; 49(4):171. PubMed ID: 7547152 [No Abstract] [Full Text] [Related]
39. [Therapy of heart failure after myocardial infarction. With eplerenone a new course]. MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524 [No Abstract] [Full Text] [Related]
40. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure. Toher CA; Francis GS Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]